238 related articles for article (PubMed ID: 18588953)
41. Endomorphin-1 and endomorphin-2, endogenous ligands for the mu-opioid receptor, inhibit electrical activity of rat rostral ventrolateral medulla neurons in vitro.
Chu XP; Xu NS; Li P; Wang JQ
Neuroscience; 1999; 93(2):681-6. PubMed ID: 10465452
[TBL] [Abstract][Full Text] [Related]
42. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the binding of [(3)H]nociceptin/orphaninFQ(1-13)NH(2), [(3)H]nociceptin/orphaninFQ(1-17)OH and [(125)I]Tyr(14)nociceptin/orphaninFQ(1-17)OH to recombinant human and native rat cerebrocortical nociceptin/orphanin FQ receptors.
Hashiba E; Lambert DG; Farkas J; Toth G; Smith G
Neurosci Lett; 2002 Aug; 328(1):5-8. PubMed ID: 12123846
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of opioid agonists on G protein expression in CHO cells expressing cloned human opioid receptors.
Xu H; Wang X; Partilla JS; Bishop-Mathis K; Benaderet TS; Dersch CM; Simpson DS; Prisinzano TE; Rothman RB
Brain Res Bull; 2008 Sep; 77(1):49-54. PubMed ID: 18639745
[TBL] [Abstract][Full Text] [Related]
45. Endomorphin-stimulated [35S]GTPgammaS binding in rat brain: evidence for partial agonist activity at mu-opioid receptors.
Sim LJ; Liu Q; Childers SR; Selley DE
J Neurochem; 1998 Apr; 70(4):1567-76. PubMed ID: 9523574
[TBL] [Abstract][Full Text] [Related]
46. Affinity labeling of delta opioid receptors by an enkephalin-derivative alkylating agent, DSLET-Mal.
Szatmári I; Orosz G; Medzihradszky K; Borsodi A
Biochem Biophys Res Commun; 1999 Nov; 265(2):513-9. PubMed ID: 10558900
[TBL] [Abstract][Full Text] [Related]
47. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
[TBL] [Abstract][Full Text] [Related]
48. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
49. Salvinorin A: allosteric interactions at the mu-opioid receptor.
Rothman RB; Murphy DL; Xu H; Godin JA; Dersch CM; Partilla JS; Tidgewell K; Schmidt M; Prisinzano TE
J Pharmacol Exp Ther; 2007 Feb; 320(2):801-10. PubMed ID: 17060492
[TBL] [Abstract][Full Text] [Related]
50. Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene.
Mizoguchi H; Wu HE; Narita M; Sora I; Hall SF; Uhl GR; Loh HH; Nagase H; Tseng LF
J Pharmacol Sci; 2003 Dec; 93(4):423-9. PubMed ID: 14737012
[TBL] [Abstract][Full Text] [Related]
51. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
Gray RE; Munks MW; Haynes RR; Olsen GD
Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
[TBL] [Abstract][Full Text] [Related]
52. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
53. Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice.
Clarke S; Zimmer A; Zimmer AM; Hill RG; Kitchen I
Neuroscience; 2003; 122(2):479-89. PubMed ID: 14614912
[TBL] [Abstract][Full Text] [Related]
54. Opioid receptors and prejunctional modulation of capsaicin-sensitive sensory nerves in guinea-pig left atrium.
Giuliani S; Maggi CA; Meli A
Gen Pharmacol; 1990; 21(4):417-21. PubMed ID: 1974221
[TBL] [Abstract][Full Text] [Related]
55. Interaction of agonist peptide [3H]Tyr-D-Ala-Phe-Phe-NH2 with mu-opioid receptor in rat brain and CHO-mu/1 cell line.
Spetea M; Otvös F; Tóth G; Nguyen TM; Schiller PW; Vogel Z; Borsodi A
Peptides; 1998; 19(6):1091-8. PubMed ID: 9700760
[TBL] [Abstract][Full Text] [Related]
56. Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype.
Pan YX; Bolan E; Pasternak GW
Biochem Biophys Res Commun; 2002 Sep; 297(3):659-63. PubMed ID: 12270145
[TBL] [Abstract][Full Text] [Related]
57. Endogenous opioid peptides and brain development: Endomorphin-1 and Nociceptin play a sex-specific role in the control of oligodendrocyte maturation and brain myelination.
Mohamed E; Paisley CE; Meyer LC; Bigbee JW; Sato-Bigbee C
Glia; 2020 Jul; 68(7):1513-1530. PubMed ID: 32065429
[TBL] [Abstract][Full Text] [Related]
58. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro.
Connor M; Vaughan CW; Chieng B; Christie MJ
Br J Pharmacol; 1996 Dec; 119(8):1614-8. PubMed ID: 8982509
[TBL] [Abstract][Full Text] [Related]
59. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the receptor binding profile of (3H)-dermorphin in the rat brain.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Int J Pept Protein Res; 1988 Dec; 32(6):506-11. PubMed ID: 2907751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
